Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Don’t forget to check out our premarket coverage here

  • Fate Therapeutics, Inc. (NASDAQ:FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday, Feb. 28, 2023.
  • Cleveland-Cliffs Inc. (NYSE:CLF) dropped 3.8% to $19.35 in pre-market trading. For the fourth quarter, the company recorded a net loss of $204 million, corresponding to a loss of $0.41 per diluted share as against a net income of $899 million, or $1.69 per diluted share in the same period of the previous quarter.
  • Vir Biotechnology, Inc. (NASDAQ:VIR) fell 3.4% to $25.30 in pre-market trading. Vir Biotechnology reported amended collaboration agreement with GSK.

Now Read This: Coca-Cola All Set To Report Earnings Today; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

 


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsSmall CapPre-Market OutlookMarketsMoversTrading Ideasbig losersTop Losers